Verrica Pharmaceuticals Ratios (2020-2026) | VRCA

Ratios Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-1,965.20%-4,750.93%18.21%-8,713.24%-17,808.11%-6,038.46%-848.54%-1,239.89%-531.10%-331.87%-1,283.49%-3,940.12%-290.67%-3.09%-2.15%-163.02%-192.59%
EBIT Margin (Quarter)
-1,719.26%-4,262.15%17.41%-9,133.82%-19,159.46%-6,382.42%-819.92%-1,163.78%-486.12%-293.72%-1,162.49%-3,316.86%-236.41%11.89%11.34%-141.24%-193.41%
EBITDA Margin (Quarter)
-1,972.85%-4,752.34%1.42%-8,680.88%-17,808.11%-6,038.46%-850.26%-1,238.13%-486.12%-293.72%-1,162.49%-3,316.86%-236.41%11.89%11.34%-141.24%-193.41%
Operating Margin (Quarter)
-1,719.26%-4,262.15%17.41%-9,133.82%-19,159.46%-6,382.42%-819.92%-1,163.78%-486.12%-293.72%-1,162.49%-3,316.86%-236.41%11.89%11.34%-141.24%-193.41%
Net Margin (Quarter)
-1,965.20%-4,750.93%1.00%-8,713.24%-17,808.11%-6,038.46%-850.26%-1,239.89%-531.10%-331.97%-1,283.49%-3,940.12%-290.67%1.61%-2.15%-163.02%-192.59%
FCF Margin (Quarter)
-1,936.19%-3,427.57%21.01%-7,382.35%-12,435.14%-2,597.80%-509.98%-741.15%-521.35%-316.19%-481.41%-4,669.77%-368.62%-78.91%67.62%-90.87%-182.42%
Efficiency
Inventory Average (Quarter)
0.65M1.76M2.60M2.64M2.52M2.46M2.49M2.41M2.27M2.10M
Assets Average (Quarter)
103.57M93.89M84.44M75.87M67.53M56.29M46.93M56.68M65.42M79.67M89.37M73.95M59.16M42.47M43.53M48.16M40.64M40.00M44.01M42.96M
Equity Average (Quarter)
56.98M46.50M36.73M29.01M20.88M30.55M42.40M52.44M60.12M48.85M31.03M10.64M-5.90M-23.68M-21.96M-14.22M-18.03M-17.26M3.85M20.40M
Invested Capital (Quarter)
93.16M82.20M74.30M67.42M58.63M44.77M40.03M64.85M55.40M84.70M62.64M44.36M29.45M9.25M21.12M9.23M7.09M4.58M24.74M17.00M
Asset Utilization Ratio (Quarter)
0.140.010.010.160.190.150.130.040.060.120.240.300.260.220.450.770.810.87
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-9.96-10.78-7.72-6.85-8.5617.88-14.43-10.04-8.02-6.42-8.71-4.86-3.690.710.78-5.47-60.72
Debt to Equity (Quarter)
0.791.011.281.652.59-1.31-0.69-0.72-0.73
Debt Ratio (Quarter)
0.410.470.520.590.670.240.300.320.30
Equity Ratio (Quarter)
0.530.460.410.350.260.910.900.940.890.440.240.02-0.26-1.03-0.18-0.44-0.45-0.420.520.41
Times Interest Earned (Quarter)
-9.96-10.78-7.72-6.85-8.5617.88-14.43-10.04-8.02-6.42-8.71-4.86-3.690.710.78-5.47-60.72
Valuation
Enterprise Value (Quarter)
-24.71M-20.44M-15.75M-50.41M-45.43M-32.47M-34.27M-59.95M-55.14M-84.31M-69.55M-48.90M-31.90M-23.00M-46.33M-29.59M-15.40M-21.10M-30.15M-20.60M
Return Ratios
Return on Sales (Quarter)
-0.03%-0.20%-0.48%0.00%-0.87%-1.78%-0.60%-0.08%-0.12%-0.05%-0.03%-0.13%-0.39%-0.03%0.00%0.00%-0.02%-0.02%
Return on Capital Employed (Quarter)
-80.52%-123.52%-168.55%-44.26%-48.98%-38.81%-39.32%-71.50%-90.89%-141.55%-206.76%-362.11%-454.03%-295.58%-339.16%-147.86%-44.19%-51.50%
Return on Assets (Quarter)
0.00%0.00%-0.01%-0.01%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%-0.01%-0.01%-0.01%0.00%0.00%
Return on Equity (Quarter)
-0.01%-0.01%-0.01%-0.02%-0.01%-0.01%0.00%0.00%-0.01%-0.02%-0.08%0.15%0.04%0.03%0.04%0.03%0.01%-0.05%-0.01%